Lower CXCR3 expression in both patients with neovascular AMD and advanced stages of chronic myeloproliferative blood cancers.

MLA

Liisborg, Charlotte, et al. “Lower CXCR3 Expression in Both Patients with Neovascular AMD and Advanced Stages of Chronic Myeloproliferative Blood Cancers.” PLoS ONE, vol. 17, no. 6, June 2022, pp. 1–16. EBSCOhost, https://doi.org/10.1371/journal.pone.0269960.

APA

Liisborg, C., Skov, V., Kjær, L., Hasselbalch, H. C., & Lykke Sørensen, T. (2022). Lower CXCR3 expression in both patients with neovascular AMD and advanced stages of chronic myeloproliferative blood cancers. PLoS ONE, 17(6), 1–16. https://doi.org/10.1371/journal.pone.0269960

Chicago

Liisborg, Charlotte, Vibe Skov, Lasse Kjær, Hans Carl Hasselbalch, and Torben Lykke Sørensen. 2022. “Lower CXCR3 Expression in Both Patients with Neovascular AMD and Advanced Stages of Chronic Myeloproliferative Blood Cancers.” PLoS ONE 17 (6): 1–16. doi:10.1371/journal.pone.0269960.